Company Name: Omeros Corporation
Omeros Corporation is a biopharmaceutical company. The company is engaged in the development and commercialization of small-molecule and protein therapeutics. Areas of focus include:
- Central nervous system disorders
The company markets OMIDRIA for use during cataract surgery and intraocular lens replacement.
Ticker Symbol: OMER (NASDAQ)
Company Website: www.omeros.com
Social Media: Omeros Corporation LinkedIn
Headquarters: Seattle, WA